首页> 外文期刊>Pregnancy hypertension >Quantification of circulating miR-517c-3p and miR-210-3p levels in preeclampsia
【24h】

Quantification of circulating miR-517c-3p and miR-210-3p levels in preeclampsia

机译:循环MiR-517C-3P和Preclampsia的MiR-210-3P水平的定量

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs, miRs) are small regulatory non-coding RNAs that regulate gene expression by incomplete complementary attachment to the 3'UTR, 5'UTR, ORF and promoter regions of target mRNAs. We compared plasma levels of miR-210-3p and miR-517c-3p as cell-free microRNAs (cfmiRNAs) in preeclamptic (n = 20) and healthy women (n = 20). These miRs are responsible for cell growth and proliferation, placental hypoxia, immune response and apoptosis. We found higher expression levels of miR-210 and miR-517c in preeclamptic cases (+ 3.34 and + 2.27 fold change, respectively). This is the first study that evaluates the plasma levels of miR-517c in preeclamptic cases by real time PCR (RT-PCR) technique. This study can lead to new opportunities for research about the roles of miRNAs in preeclampsia etiology or new biomarkers.
机译:MicroRNAS(miRNA,miR)是小型调节性非编码RNA,其通过对3'UTR,5'UTR,ORF和靶MRNA的启动子区域的不完全互补附着来调节基因表达。 将MiR-210-3P和MIR-517C-3P的血浆水平与预克里羊醛(N = 20)和健康女性(N = 20)进行了无细胞微小RNA(CFMIRNA)。 这些miR负责细胞生长和增殖,胎盘缺氧,免疫应答和凋亡。 我们发现较高的miR-210和miR-517c在预克切式病例中的表达水平(分别分别为+ 3.34和+ 2.27倍变化)。 这是通过实时PCR(RT-PCR)技术在预克切尔病例中评估miR-517c的血浆水平的第一研究。 本研究可以导致研究MiRNA在预先普利坦斯病因或新生物标志物中的创新机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号